Table 3 Non-hemodialysis patients’ demographic profiles, backgrounds, levofloxacin concentrations, and protein binding ratios
From: No effect of protein binding ratio of levofloxacin in hemodialysis patients
Patient no. | Age (years) | Sex | BW (kg) | Scr (mg/dL) | BST (h) | SP (g/dL) | SA (g/dL) | LVFX (mg/L) | PBR (%) |
|---|---|---|---|---|---|---|---|---|---|
1 | 59 | Female | 63.8 | 0.9 | Just before administration | 6.6 | 3.7 | 4.8 | 38.8 |
2 | 95 | Female | 35.0 | 0.7 | Just before administration | 6.2 | 2.9 | 7.7 | 31.6 |
3 | 88 | Female | 33.3 | 0.4 | Just before administration | 6.3 | 3.4 | 3.1 | 37.5 |
4 | 87 | Female | 32.8 | 0.4 | Just before administration | 6.8 | 3.0 | 1.2 | 27.7 |
5 | 72 | Male | 43.9 | 1.0 | 12 h | 5.9 | 2.6 | 5.7 | 24.8 |
6 | 86 | Female | 57.2 | 1.0 | 12 h | 5.9 | 3.3 | 7.4 | 27.0 |
7 | 79 | Female | 45.7 | 0.5 | Just before administration | 6.7 | 2.8 | 1.6 | 31.2 |
Average | 80.9 | – | 44.5 | 0.7 | – | 6.3 | 3.1 | 4.5 | 31.2 |
SD | 12.1 | – | 12.2 | 0.3 | – | 0.4 | 0.4 | 2.6 | 5.3 |